Both in Biotechnology
Tevogen vs LENZ Therapeutics
Over the past year TVGN returned −79.7% and LENZ returned −87.3%; their daily moves had a correlation of -0.03.
TVGN −79.7% LENZ −87.3%Growth of $1, one year, split-adjusted
| Metric | TVGN | LENZ |
|---|---|---|
| Price | $5.97 | $3.55 |
| Market cap | $93.9M | $111.5M |
| Today | +6.80% | +16.39% |
| 1 month | −9.5% | −1.1% |
| 6 months | −19.0% | −60.9% |
| Year to date | −63.9% | −77.8% |
| 1 year | — | −88.1% |
| Revenue growth (YoY) | — | +9.7% |
| Gross margin | — | 94.9% |
| Net margin | — | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.2× |
| Net cash | -$7.0M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 77.2% |
| Short % of float | 3.9% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).